… Twenty-one eligible studies comprising 2611 patients with pyoderma gangrenosum were …
In 16.3% (95% confidence interval 7.7–27.1) of cases, the onset of pyoderma gangrenosum …

… cutaneous manifestations are erythema nodosum and pyoderma gangrenosum (PG). It has
… A recent meta-analysis indicated that systemic disease is associated with 57% of PG, and …

… Boolean operators were used such that all literature addressing both ‘pyoderma gangrenosum’
AND ‘systemic therapies’ was captured in the search string. We critically appraised and …

… Pyoderma gangrenosum (PG) is an inflammatory disease characterized by painful skin
ulcerations with undermined and erythematous borders. The etiology of PG is not well …

… We performed a systematic review in PubMed, EMBASE, and Scopus from inception to
present using the terms arthritis and pyoderma gangrenosum. Patient demographics, clinical …

… Similar results were found in a large meta-analysis of 21 studies including 2,611 patients; in
this study, the prevalence of immune-related systemic diseases in PG was 56.8% (ref. ), with …

… in pyoderma gangrenosum and its syndromic form (pyoderma gangrenosum, acne and sup…
Failure of anakinra treatment of pyoderma gangrenosum in an IBD patient and relevance to …

… Peristomal pyoderma gangrenosum (PPG) is an uncommon subtype of pyoderma gangrenosum.
PPG is a challenging condition to diagnose and treat; no evidence-based guidelines …

… Cutaneous vasculitis and pyoderma gangrenosum are the … Pyoderma gangrenosum is
a noninfectious neutrophilic … However, pyoderma gangrenosum (PG) remains idiopathic …

… Pyoderma gangrenosum is not always correctly coded (ICD‐9 code 686.01) by clinicians, …
the term ‘pyoderma gangrenosum’ appeared within the notes. A careful analysis revealed …